Vestmark Advisory Solutions’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,181
Closed -$533K 1495
2026
Q1
$533K Sell
6,181
-794
-11% -$71.3K 0.01% 1049
2025
Q4
$609K Buy
+6,975
New +$529K 0.01% 942
2023
Q1
Sell
-81,442
Closed -$6.05M 880
2022
Q4
$6.05M Buy
81,442
+27,950
+52% +$1.9M 0.29% 73
2022
Q3
$3.19M Buy
53,492
+1,924
+4% +$116K 0.18% 155
2022
Q2
$2.9M Buy
+51,568
New +$3.39M 0.17% 159

Other funds holding GMED

Vestmark Advisory Solutions's GMED Position: Q2 2026 in Review

Vestmark Advisory Solutions sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 6,181 shares — an estimated $533K sold.

Vestmark Advisory Solutions first reported a position in GMED in Q2 2022 and held it in 5 quarters. The position peaked at $6.05M in Q4 2022. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Vestmark Advisory Solutions reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 6,181 Globus Medical shares in Q2 2026, an estimated $533K.
  • Vestmark Advisory Solutions first reported a position in Globus Medical in Q2 2022 and held it in 5 quarters.
  • Vestmark Advisory Solutions's Globus Medical position peaked at $6.05M in Q4 2022.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.